The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry
No Thumbnail Available
Date
2018-09
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Keywords
Rheumatology
Citation
Uslu, S. vd. (2018). ''The efficacy and drug survival of the biosimilar infliximab (ct-p13) compared to the original reference infliximab in inflammatory rheumatic diseases; Results from the turkbio registry''. Arthritis & Rheumatology, 70(Supplement 9).